The primary screening marker for thyroid function is TSH (thyroid-stimulating hormone). However, an abnormal TSH alone is insufficient for a full assessment. Clinically relevant blood markers include: free T4 (fT4) and free T3 (fT3), which reflect the actual available thyroid hormones. Autoantibodies such as anti-TPO (thyroid peroxidase) and anti-Tg (thyroglobulin) indicate autoimmune causes (Hashimoto's thyroiditis). For suspected Graves' disease, TRAb (TSH receptor antibodies) is measured. Additional markers like thyroglobulin or calcitonin are used in specific contexts (e.g., cancer follow-up). Importantly, MyBody-X analyzes genetic variants that may be associated with thyroid function (e.g., in TSHR, PDE8B genes), but it does not measure current hormone levels. A blood test ordered by a physician is essential for clinical evaluation. The evidence for these blood markers is strong (guidelines, clinical trials).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-a959432ef72059714285b779